Browse > Article

A Case of Nonvasculitic Autoimmune Inflammatory Meningoencephalitis Accompanied by Sj$\ddot{o}$gren's Syndrome and Elevated Antithyroid Antibodies  

Lee, Seong-Joon (Department of Neurology, Ajou University School of Medicine)
Sohn, Sung-Yeon (Department of Neurology, Ajou University School of Medicine)
Lim, Tae-Sung (Department of Neurology, Ajou University School of Medicine)
Moon, So-Young (Department of Neurology, Ajou University School of Medicine)
Publication Information
Dementia and Neurocognitive Disorders / v.10, no.3, 2011 , pp. 102-105 More about this Journal
Abstract
Background: Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM) is known to be one of the causes of potentially reversible dementia. NAIM can be accompanied by various autoimmune diseases. Methods: A 65 year-old woman had been treated with stable bipolar disorder and presented with rapid cognitive decline, visual hallucination and myoclonus. Anti-thyroid antibodies were elevated. Her symptoms were responsive to steroid therapy. Her diagnostic evaluation also revealed Sj$\ddot{o}$gren's syndrome. Although her symptoms recovered, a manic episode reappeared and was responsive to psychiatric treatment. Conclusions: Patients presenting with rapidly progressive dementia should be thoroughly evaluated for the diagnosis of NAIM, a potentially treatable form of dementia, and the possible various underlying autoimmune etiologies.
Keywords
Nonvasculitic autoimmune inflammatory meningoencephalitis; Sj$\ddot{o}$gren's syndrome; Steroid responsive encephalopathy associated with autoimmune thyroiditis; Bipolar disorder;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Caselli RJ, Boeve BF, Scheithauer BW, O'Duffy JD, Hunder GG. Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. Neurology 1999; 53: 1579-81.   DOI
2 Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 2006; 6: 197-202.
3 Brain L, Jellinek E, Ball K. Hashimoto's disease and encephalopathy. Lancet 1966; 2: 512-4.
4 Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL. Rapidly progressive dementia. Ann Neurol 2008; 64: 97-108.   DOI   ScienceOn
5 Ozgocmen S, Gur A. Treatment of central nervous system involvement associated with primary Sjogren's syndrome. Curr Pharm Des 2008; 14: 1270-3.   DOI   ScienceOn
6 Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et al. Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine 2004; 83: 280-91.   DOI   ScienceOn
7 Caselli RJ, Scheithauer BW, Bowles CA, Trenerry MR, Meyer FB, Smigielski JS, et al. The treatable dementia of Sjogren's syndrome. Ann Neurol 30: 98-101, 199.   DOI   ScienceOn
8 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.   DOI   ScienceOn
9 Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.   DOI   ScienceOn
10 Josephs KA, Rubino FA, Dickson DW. Nonvasculitic autoimmune inflammatory meningoencephalitis. Neuropathology 2004; 24: 149-52.   DOI   ScienceOn
11 Lyons MK, Caselli RJ, Parisi JE. Nonvasculitic autoimmune inflammatory meningoencephalitis as a cause of potentially reversible dementia: report of 4 cases. J Neurosurg 2008; 108: 1024-7.   DOI   ScienceOn